News

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2024.03.12
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2023.11.13
Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

Archive

2021.11.25

Miron Tokarski Awarded with Laureate of “Leaders of the Future” Ranking by Forbes

Miron Tokarski, co-founder and CEO of Genomtec, found himself among the honourable laureates of the Forbes Magazine ranking: “Leaders of ...
Read
2021.11.19

Genomtec receives sixth patent protecting the Company’s technology for HPV-16 genetic diagnostics

Genomtec has received patent protection from the Polish Patent Office for a primer set for the detection of Human papillomavirus-16 (HPV16), a ...
Read
2021.11.08

Genomtec gets closer to commercializing its Genomtec®ID platform – Q3 2021 summary

Genomtec released its Q3 2021 report. Q3 was a period of intensified work on Genomtec®ID – the company obtained 2 additional patents (in ...
Read
2021.11.03

Genomtec to accelerate commercialization of Genomtec®ID

Genomtec started today the analysis to accelerate the planned commercialization of the Genomtec®ID platform. The analysis will include the ...
Read
2021.10.29

Genomtec submits Prospectus to the Polish Financial Supervision Authority

Genomtec today filed with the Polish Financial Supervision Authority (KNF) a prospectus prepared in connection with the planned transfer of the ...
Read
2021.10.28

Genomtec secures fifth patent for its invention

Genomtec has received notification from the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) ...
Read

Archive